The Alcohol Dependence drugs in development market research report provides comprehensive information on the therapeutics under development for Alcohol Dependence, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Alcohol Dependence. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Alcohol Dependence and features dormant and discontinued products.
GlobalData tracks 76 drugs in development for Alcohol Dependence by 65 companies/universities/institutes. The top development phase for Alcohol Dependence is preclinical with 36 drugs in that stage. The Alcohol Dependence pipeline has 68 drugs in development by companies and eight by universities/ institutes. Some of the companies in the Alcohol Dependence pipeline products market are: AWAKN Life Sciences, Camino Pharma and BioCorRx.
The key targets in the Alcohol Dependence pipeline products market include 5-Hydroxytryptamine Receptor 2A, Mu Type Opioid Receptor, and 5-Hydroxytryptamine Receptor 1A.
The key mechanisms of action in the Alcohol Dependence pipeline product include 5-Hydroxytryptamine Receptor 2A Agonist with ten drugs in Phase II. The Alcohol Dependence pipeline products include ten routes of administration with the top ROA being Oral and four key molecule types in the Alcohol Dependence pipeline products market including Small Molecule, and Synthetic Peptide.
Alcohol Dependence overview
Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking, and violent behavior. Risk factors include age, family history, and depression or other mental health problems.
For a complete picture of Alcohol Dependence’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
